Orphan Drug Developer Ultragenyx Licenses Kyowa Hakko Kirin’s X-Linked Hypophosphataemia Drug |
Abstract
|
Heather Cartwright |
|
Roche Looks to Combination Immunotherapies with Inovio DNA Vaccine Collaboration |
Abstract
|
Heather Cartwright |
|
Amgen and Onyx Finally Agree to US$10.4 B Takeover |
Abstract
|
Heather Cartwright |
|
Astex Accepts Takeover Offer from Otsuka Regarded As Too Low By Many |
Abstract
|
Heather Cartwright |
|
Cornerstone Therapeutics Accepts Sweetened Buyout Offer from Majority Shareholder Chiesi |
Abstract
|
Heather Cartwright |
|